AKSA:BISTAksa Akrilik Kimya Sanayii A.S. Analysis

AKSA trades at TRY 10.65, slightly below its 20‑day (≈10.77), 50‑day (≈10.73) and 200‑day (≈10.72) moving averages, indicating a modest price lag despite a computed bullish trend direction. The RSI sits at 48.7, suggesting neutral momentum, while the MACD histogram is negative and the signal line is bearish, hinting at short‑term downside pressure. Volume is on a decreasing trajectory, and 30‑day volatility is high at 46%, though the beta of 0.17 points to low systematic risk. On the valuation side, the stock offers a low trailing PE of 9.5x and a modest PB of 1.26x, but the DCF‑derived fair value of TRY 6.49 is well below the current price, implying potential overvaluation. The dividend yield is attractive at 5.3% with a payout ratio near 95%, yet free cash flow is negative and debt levels are steep (Debt‑to‑Equity ≈ 78%), raising sustainability concerns. Analysts rate the stock as a strong buy with a median target of TRY 15.5, indicating expectations of significant upside.
Given the mix of strong cash‑flow generation from operations (OCF ≈ TRY 5.1 bn) and high leverage, the medium‑term upside to analyst targets appears plausible, but the short‑term risk of a pull‑back toward the support level of TRY 9.99 remains. The high dividend yield may not be sustainable without improved free cash flow, and the company’s exposure to Turkish macro‑economic and regulatory dynamics adds a layer of geographic and sector risk. Consequently, a cautious stance is advised: hold in the near term, consider buying on a dip for investors comfortable with the leverage profile, and maintain a watchful long‑term position pending clearer cash‑flow trends.